Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer

Oliver S Eng; Kiran K Turaga

doi:10.1002/jso.25438

Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer

J Surg Oncol. 2019 Apr;119(5):613-615. doi: 10.1002/jso.25438. Epub 2019 Mar 10.

Authors

Oliver S Eng¹, Kiran K Turaga¹

Affiliation

¹ Department of Surgery, University of Chicago, Chicago, Illinois.

PMID: 30852849
DOI: 10.1002/jso.25438

Abstract

As the management of metastatic colorectal cancer (CRC) has evolved over the past decades, optimal management of CRC with peritoneal metastases remains controversial, especially about cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. In this review, we highlight the current data on this challenging disease process, as well as comment on its limitations.

Keywords: colon cancer; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; intraperitoneal chemotherapy; peritoneal metastases; rectal cancer.

Publication types

Review

MeSH terms

Colorectal Neoplasms / pathology*
Colorectal Neoplasms / therapy
Cytoreduction Surgical Procedures / methods*
Humans
Hyperthermia, Induced / methods*
Peritoneal Neoplasms / secondary*
Peritoneal Neoplasms / therapy*